KIA
MGNX icon

Kraematon Investment Advisors’s MacroGenics MGNX Stock Holding History

Kraematon Investment Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-900
Closed -$6.04K – 177
2022
Q4 		$6.04K Buy
+900
New +$4.94K 0.01% 218

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Kraematon Investment Advisors's MGNX Position: Q1 2023 in Review

Kraematon Investment Advisors sold out of MacroGenics (MGNX) in Q1 2023, closing a stake of 900 shares — an estimated $6.04K sold.

Kraematon Investment Advisors first reported a position in MGNX in Q4 2022 and held it in 1 quarter. The position peaked at $6.04K in Q4 2022. 137 funds tracked by Wall St. Rank hold MGNX as of Q1 2023.

  • Kraematon Investment Advisors reported no remaining MacroGenics position as of Q1 2023 after selling out during the quarter.
  • Kraematon Investment Advisors sold 900 MacroGenics shares in Q1 2023, an estimated $6.04K.
  • Kraematon Investment Advisors first reported a position in MacroGenics in Q4 2022 and held it in 1 quarter.
  • Kraematon Investment Advisors's MacroGenics position peaked at $6.04K in Q4 2022.
  • 137 funds tracked by Wall St. Rank held MacroGenics as of Q1 2023.

Based on Kraematon Investment Advisors's 13F filing for Q1 2023, filed 13 Apr 2023.